BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1534346)

  • 1. Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy.
    Thorisdottir H; Evans JA; Schwartz HJ; Comp P; Haluschak J; Ratnoff OD
    J Lab Clin Med; 1992 Jun; 119(6):698-701. PubMed ID: 1534346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of danazol on plasma levels of protein S C4b-binding protein].
    Shimmyozu K; Kadokura N; Tara M; Maruyama I; Osame M
    Rinsho Ketsueki; 1990 Jun; 31(6):860-1. PubMed ID: 2145451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in haematological indices, blood viscosity and inhibitors of coagulation during treatment of endometriosis with danazol.
    Ford I; Li TC; Cooke ID; Preston FE
    Thromb Haemost; 1994 Aug; 72(2):218-21. PubMed ID: 7831655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The localization of heparin-binding fragments on human C4b-binding protein.
    Hessing M; Vlooswijk RA; Hackeng TM; Kanters D; Bouma BN
    J Immunol; 1990 Jan; 144(1):204-8. PubMed ID: 2136880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of danazol therapy in endometriosis on the blood picture and blood coagulation].
    Schweppe KW; Ebert C; Cirkel U
    Geburtshilfe Frauenheilkd; 1988 Sep; 48(9):634-6. PubMed ID: 3181711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
    Dahlbäck B
    Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of the synthetic androgen, danazol, to increase protein S levels and prevent thrombosis in a patient with severe protein S deficiency.
    Bower WA; Humphries JE
    Haemostasis; 1995; 25(3):144-8. PubMed ID: 7607583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
    García de Frutos P; Dahlbäck B
    J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of plasma protein S--the protein cofactor of activated protein C.
    Bertina RM; van Wijngaarden A; Reinalda-Poot J; Poort SR; Bom VJ
    Thromb Haemost; 1985 Apr; 53(2):268-72. PubMed ID: 3161206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of different forms of human C4b-binding protein lacking beta-chain and protein S binding ability.
    Hessing M; Kanters D; Hackeng TM; Bouma BN
    Thromb Haemost; 1990 Oct; 64(2):245-50. PubMed ID: 2148654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally high level of C4b binding protein and deficiency of free fraction of protein S in a patient with systemic lupus erythematosus and recurrent thromboses.
    Stankiewicz AJ; Steiner M; Lally EV; Kaplan SR
    J Rheumatol; 1991 Jan; 18(1):82-7. PubMed ID: 1827159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.
    Seya T; Nagasawa S; Atkinson JP
    J Immunol; 1990 Mar; 144(6):2312-20. PubMed ID: 1690242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of thrombin-resistant variants of recombinant human protein S.
    Chang GT; Aaldering L; Hackeng TM; Reitsma PH; Bertina RM; Bouma BN
    Thromb Haemost; 1994 Nov; 72(5):693-7. PubMed ID: 7900076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chain.
    Hessing M; van 'T Veer C; Bouma BN
    J Immunol; 1990 Apr; 144(7):2632-7. PubMed ID: 2319131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C, protein S and C4b-binding protein in severe infection and septic shock.
    Hesselvik JF; Malm J; Dahlbäck B; Blombäck M
    Thromb Haemost; 1991 Feb; 65(2):126-9. PubMed ID: 1828915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
    Forastiero RR; Kordich L; Basilotta E; Carreras LO
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein.
    Merrill JT; Zhang HW; Shen C; Butman BT; Jeffries EP; Lahita RG; Myones BL
    Thromb Haemost; 1999 May; 81(5):748-57. PubMed ID: 10365749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal coagulation inhibitors and the effects of cesarean delivery.
    Banias BB; Nolan TE; Devoe LD; Krauss JS
    J Reprod Med; 1992 Aug; 37(8):741-4. PubMed ID: 1432992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein S and C4b-binding protein levels in patients with stroke: implications for protein S regulation.
    Carr ME; Zekert SL
    Haemostasis; 1993; 23(3):159-67. PubMed ID: 8276319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein S, C4b binding protein, and the hypercoagulable state.
    Taylor FB
    J Lab Clin Med; 1992 Jun; 119(6):596-7. PubMed ID: 1534344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.